Our Approach & Expertise

Our Publications Visit PubMed for our journal articles go

Through these cooperative groups, Memorial Sloan-Kettering is a leading participant in most of the national trials to improve the detection, treatment, and prevention of upper gastrointestinal cancers. One of our main areas of research focuses on the identification of novel therapeutic drugs and targets, as well as treatment modalities and programs to improve the care of patients with upper gastrointestinal malignancies.

Barrett's Esophagus Screening

We offer screening for patients with Barrett's esophagus, a precancerous condition of the esophagus that may be caused by the chronic, abnormal exposure of the esophagus to acid (in most cases, stomach acid).

The Leading Edge of Surgical Expertise

An active program in minimally invasive surgery is available for evaluation and treatment of many gastrointestinal cancers and precancerous conditions.

Our surgeons, among the world's most experienced in treating esophageal cancers, are often able to completely remove such tumors. When tumors cannot be removed, new laser techniques can rapidly relieve obstructions that may cause pain and disability in patients with esophageal and stomach cancers.

Find a Clinical Trial Find out about new research studies for esophageal cancer more

Innovative Systemic Treatments

Having pioneered systemic therapy -- treatment applied to the entire body -- for esophageal cancers, Memorial Sloan-Kettering is working to develop better chemotherapy agents for use alone and in combination. We offer innovative, combined-modality treatments for esophageal cancer using new drug combinations plus radiation therapy both before and instead of surgery. And for patients with more advanced disease, we are studying new, targeted drug agents.